Reps. Wexton, Herrera Beutler Lead Bipartisan Letter Urging FDA to Protect Women's Access to Compounded Hormone Therapies
December 15, 2021
December 15, 2021
WASHINGTON, Dec. 15 -- Rep. Jennifer Wexton, D-Virginia, issued the following news release:
U.S. Representatives Jennifer Wexton (D-VA) and Jaime Herrera Beutler (R-WA) sent a bipartisan letter urging the Food and Drug Administration (FDA) to preserve access for millions of women and other patient populations to compounded hormone therapy treatment options.
Wexton and Herrera Beutler are taking action in response to a recent report from the National Academies of Science . . .
U.S. Representatives Jennifer Wexton (D-VA) and Jaime Herrera Beutler (R-WA) sent a bipartisan letter urging the Food and Drug Administration (FDA) to preserve access for millions of women and other patient populations to compounded hormone therapy treatment options.
Wexton and Herrera Beutler are taking action in response to a recent report from the National Academies of Science . . .